The evolution of home high-flow therapy and its implications for patient care

In this episode we’re joined by Dr Maxime Patout, who’s at the forefront of new research into home high-flow therapy (HFT). Listen now to find out why he thinks the evolving role of home HFT – especially in out-of-hospital care – means we’re on the verge of important change in respiratory medicine, with benefits for patients, healthcare professionals and healthcare systems. If you’d like to hear more from Dr Patout on this topic, tune in next time, when he’ll be offering insights into the French clinical trial HiFAE, and why it is important for increasing evidence in this field. 

Guest:

• Dr Maxime Patout - Hospital Pitié Salpêtrière, Faculty of Medicine, Sorbonne University, France.

Host:

• Daniela Gautschi is ResMed’s Director Clinical Advocacy Europe, and has a passion for exploring the latest developments in the world of sleep and breathing health. Her key focus is advocating for digital health innovations to help ensure access to good quality care.

Disclaimers:

• This content is intended for health professionals only.
• This testimonial is a genuine and documented account of the individual’s response to treatment. Outcomes and results may vary, and this individual’s response does not provide any indication, warranty or guarantee that other people will have the same or a similar experience. This presentation is based on the professional presenter experience, practice and on recent available relevant data which is not intended to be understood as state of the art.
• Dr Maxime Patout was provided with a nominal financial incentive for providing the following testimonial. Dr Maxime Patout will not receive any discounts or further incentives as a result of this testimonial.

Listen to OnAir with Clinical Respiratory News, the podcast that brings you fresh insights and thought-provoking discussions about hot topics in respiratory care and sleep-disordered breathing.

© ResMed